7Baggers
Quarterly
Annual
    Unit: USD2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31 2010-09-30 2010-06-30 2010-03-31 2009-12-31 2009-09-30 2009-06-30 2009-03-31 2008-12-31 2008-09-30 2008-06-30 2008-03-31 2007-12-31 2007-09-30 2007-06-30 2007-03-31 2006-12-31 2006-09-30 2005-12-31 2005-09-30 2005-06-30 2005-03-31 2004-12-31 2004-09-30 2004-06-30 2004-03-31 2003-12-31 2003-09-30 2003-06-30 2003-03-31 
      
    		                                                                                         
      cash flows from operating activities:
    		                                                                                         
      net income
    		71,708,000 39,260,000 20,737,000 30,480,000 19,441,000 -153,025,000 4,035,000 -124,287,000 21,391,000 28,282,000 14,206,000 29,659,000 30,728,000 27,136,000 -21,188,000 47,516,000 30,795,000 35,011,000 17,642,000 -64,296,000 -41,044,000 -672,436,000 -18,712,000 9,331,000 -1,255,916,000 -8,245,000 -242,872,000 60,214,000 65,575,000 79,412,000 63,428,000 136,103,000 65,880,000 63,698,000 54,691,000 78,079,000 96,421,000 82,325,000 67,771,000 92,414,000 90,640,000 84,048,000 68,589,000 88,280,000 86,238,000 79,025,000 63,660,000 78,974,000 76,958,000 69,218,000 55,367,000 66,103,000 65,910,000 60,544,000 48,350,000 58,359,000 58,241,000 55,941,000 45,456,000 53,800,000 61,270,000 49,358,000 38,263,000 50,401,000 48,134,000 43,217,000 34,052,000 38,985,000 37,396,000 37,014,000 55,806,000 41,267,000 39,558,000 36,315,000 25,582,000   15,870,000 28,057,000 27,127,000 17,983,000 25,785,000 25,943,000 25,235,000 21,316,000 23,971,000 23,473,000 19,885,000 16,999,000 
      adjustments to reconcile net income to net cash from operating activities:
    		                                                                                         
      depreciation and amortization
    		5,551,000 5,313,000 5,332,000 6,873,000 6,254,000 8,791,000 10,308,000 9,062,000 9,211,000 8,945,000 8,953,000 9,136,000 8,956,000 8,775,000 8,769,000 7,859,000 8,151,000 8,106,000 8,031,000 7,692,000 -8,043,000 10,119,000 18,673,000 19,410,000 19,608,000 19,809,000 20,033,000 29,891,000 28,709,000 26,518,000 26,163,000 26,414,000 25,116,000 25,735,000 25,614,000 25,254,000 24,185,000 20,241,000 19,584,000 18,149,000 16,918,000 15,549,000 13,612,000 13,902,000 11,356,000 10,362,000 10,370,000 10,491,000 10,461,000 9,870,000 9,144,000 8,091,000 7,925,000 7,687,000 7,113,000 7,266,000 6,213,000 6,032,000 5,781,000 5,843,000 6,321,000 5,006,000 4,780,000 4,610,000 3,956,000 4,187,000 3,963,000 4,020,000 3,296,000 2,939,000 2,955,000 3,047,000 2,577,000 2,466,000 2,473,000   2,400,000 2,339,000 2,529,000 2,647,000  2,299,000 2,337,000 2,363,000     
      amortization of premiums, discounts and issuance costs
    		240,000 228,000 230,000 251,000 263,000 240,000 200,000 224,000 282,000 340,000 393,000 419,000 489,000 280,000 577,000 815,000 1,682,000 844,000 994,000 3,087,000 1,291,000 1,327,000 1,458,000 1,379,000 1,359,000 1,414,000 1,520,000 1,258,000 1,102,000 1,123,000 1,089,000 1,436,000 1,338,000 1,357,000 1,383,000 739,000 1,384,000 1,397,000 1,296,000                                                   
      impairment losses
    		                                                                                         
      loss on disposal of businesses
    		    59,000                                                                                     
      net gain on investments in divested businesses
    		                                                                                         
      stock-based compensation expense
    		5,150,000 3,909,000 3,641,000 2,739,000 4,110,000 1,952,000 3,067,000 3,024,000 3,164,000 3,126,000 3,009,000 3,236,000 4,120,000 4,336,000 4,435,000 4,021,000 5,495,000 5,735,000 3,717,000 2,922,000 22,301,000 5,784,000 8,035,000 6,379,000 8,022,000 9,961,000 10,989,000 9,359,000 8,945,000 10,524,000 9,875,000 7,040,000 7,752,000 7,245,000 7,536,000 8,111,000 8,649,000 8,327,000 8,913,000 8,169,000 8,196,000 7,928,000 7,836,000 7,805,000 8,065,000 7,778,000 8,071,000 8,099,000 8,097,000 7,808,000 7,284,000 7,996,000 7,352,000 6,053,000 7,036,000 7,055,000 6,832,000 6,693,000 6,512,000 6,594,000 6,665,000 6,315,000 6,119,000 6,434,000 6,472,000 5,731,000 5,683,000 5,514,000 5,373,000 4,942,000 4,947,000 5,278,000 4,361,000 3,846,000 4,476,000               
      deferred income taxes
    		11,135,000 12,106,000 4,398,000 13,750,000 9,148,000 -25,714,000 686,000 -7,350,000 2,213,000 6,368,000 2,008,000 -14,069,000 -6,808,000 -4,283,000 2,389,000 -1,048,000 -13,158,000 -1,017,000 -16,016,000 6,078,000 -25,598,000 22,230,000 33,582,000 -22,311,000 -143,736,000 -5,845,000 -5,108,000 -7,221,000 4,283,000 -21,256,000 45,000 -76,804,000 -1,723,000 16,270,000 2,184,000 1,873,000 -1,805,000 15,486,000 2,595,000 11,624,000 -14,665,000 15,512,000 2,023,000 -7,851,000 2,918,000 7,879,000 -387,000 -3,420,000 3,130,000 20,582,000 -4,372,000 4,613,000 6,407,000 21,460,000 -11,136,000 2,509,000 1,367,000 2,924,000 1,263,000 18,143,000 816,000 7,231,000 -1,815,000 9,211,000 1,229,000 3,927,000 -6,920,000 -20,415,000 -3,213,000 4,986,000 4,993,000 -5,477,000 -7,417,000 5,648,000 230,000   833,000 -4,093,000 4,202,000 609,000  616,000 363,000 6,188,000     
      other
    		-1,885,000 -743,000 -758,000 -966,000 -328,000 -413,000 -1,265,000 -1,560,000 -707,000 -509,000 -391,000 2,523,000 -802,000 -972,000 -605,000 -711,000 -434,000 -567,000 -638,000 -168,000 2,062,000 -209,000 -1,883,000 1,458,000 -14,219,000 10,383,000 2,767,000 -7,873,000 -882,000 -932,000 -1,216,000 -1,303,000 927,000 -651,000 -2,756,000                                                       
      changes in assets and liabilities:
    		                                                                                         
      accounts receivable
    		7,870,000 3,770,000 17,461,000 9,657,000 1,569,000 9,002,000 -9,936,000 4,181,000 -6,805,000 7,555,000 21,345,000 -5,042,000 15,449,000 4,202,000 -20,152,000 -30,704,000 -16,022,000 -14,372,000 -11,633,000 7,931,000 -14,290,000 18,392,000 25,904,000 -4,170,000 9,491,000 18,448,000 -15,915,000 -17,771,000 5,171,000 14,612,000 -38,610,000 16,888,000 -27,446,000 7,283,000 11,078,000 -9,188,000 -8,584,000 4,861,000 -21,089,000 -37,768,000 -15,498,000 6,558,000 -8,683,000 -7,022,000 -7,983,000 -11,721,000 -30,292,000 -12,583,000 -3,040,000 -5,954,000 -15,754,000 2,441,000 -9,587,000 -4,203,000 -6,329,000 -23,328,000 -13,028,000 -5,862,000 -6,775,000 -6,673,000 4,261,000 -4,998,000 -9,541,000 -421,000 -588,000 1,793,000 -2,833,000 -10,985,000 -2,805,000 -4,571,000 1,432,000 -4,551,000 -9,979,000 -5,063,000 -2,200,000   -1,851,000 -4,024,000 -441,000 2,451,000  -8,055,000 -2,406,000 -3,726,000     
      prepaid expenses and other current assets
    		-988,000 1,329,000 -1,125,000 -2,448,000 2,242,000 -53,000 3,756,000 -3,776,000 2,149,000 6,611,000 -4,470,000 -6,781,000 5,665,000 832,000 16,212,000 15,139,000 -14,409,000 -6,999,000 47,799,000 -46,240,000 14,565,000 -21,382,000 5,101,000 -2,378,000 -8,425,000 -3,985,000 4,790,000 -121,000 -4,173,000 -2,139,000 961,000 -3,039,000 913,000 -3,808,000 3,142,000 338,000                                             1,584,000    571,000     
      other long-term assets
    		7,371,000 4,952,000 4,649,000 3,159,000 13,614,000 11,055,000 5,900,000 9,508,000 8,291,000 4,100,000 952,000 6,036,000 4,190,000 6,107,000 863,000 387,000 11,271,000 -1,769,000 -90,000 6,213,000 2,143,000 -5,629,000 11,189,000 7,461,000 16,492,000 4,456,000 9,580,000 1,559,000   -517,000     -244,000 9,484,000                                                     
      accounts payable and accrued expenses
    		51,118,000 69,734,000 -159,685,000 85,294,000 48,763,000 58,546,000 -141,463,000 44,197,000 41,197,000 52,810,000 -150,125,000 76,859,000 14,547,000 68,285,000 -159,271,000 26,642,000 49,137,000 52,484,000 -106,937,000 84,341,000 50,176,000 111,843,000 -198,452,000 79,682,000 81,584,000 75,454,000 -132,559,000 53,525,000 62,307,000 35,866,000 -136,308,000 34,349,000 78,064,000 64,005,000 -151,867,000 44,245,000 59,208,000 43,520,000 -135,356,000 44,860,000 66,793,000 50,095,000 -169,622,000 78,612,000 51,776,000 67,021,000 -131,370,000 52,582,000 50,066,000 54,315,000 -107,724,000 31,652,000 43,034,000 56,629,000 -114,362,000 34,662,000 38,988,000 37,548,000 -89,718,000 8,407,000 25,059,000 37,847,000 -108,316,000 26,354,000 43,908,000 47,081,000 -77,862,000 67,174,000 32,629,000 32,483,000 -73,346,000 39,733,000 32,783,000 33,438,000 -60,764,000   29,536,000 19,887,000 21,347,000 -35,012,000  20,777,000 15,992,000 -37,554,000     
      payment of contingent consideration liability
    		                                                            0                             
      income taxes payable
    		4,614,000 2,015,000 2,748,000  -4,208,000 8,718,000 3,017,000  6,874,000 -17,327,000 5,299,000            -32,883,000 1,718,000 3,105,000 -43,315,000 14,373,000 8,930,000 -30,277,000 -1,124,000 -38,785,000 47,628,000 41,322,000 -44,879,000 28,979,000 -11,164,000 15,066,000 -25,565,000 19,429,000 -20,055,000 28,089,000 -31,687,000 19,552,000 1,496,000 2,493,000 -23,067,000 26,076,000 906,000 8,790,000 -31,553,000 27,629,000 -7,185,000 3,154,000 -33,635,000 30,323,000 4,966,000 -683,000 -12,755,000 15,176,000 1,148,000 3,495,000 -10,018,000 24,081,000 -20,336,000 -274,000 -17,953,000 19,679,000 -8,354,000 3,534,000 -22,498,000 22,616,000 14,267,000 2,052,000 -771,000 -9,454,000   -4,497,000 13,788,000 53,000 10,463,000    2,887,000     
      long-term professional liabilities
    		760,000 -576,000 -7,590,000 4,064,000 5,200,000 3,957,000 4,082,000 -1,000 0 -1,540,000 2,378,000 -1,760,000 10,128,000 -5,452,000 2,684,000 966,000 1,272,000 201,000 -916,000 -11,367,000 12,772,000 -4,038,000 6,969,000 9,023,000 4,295,000 -2,978,000 -496,000 -1,882,000 3,255,000 -5,220,000 -643,000 9,677,000 7,785,000 2,521,000 -1,505,000 -6,905,000 -69,000 1,921,000 1,601,000 -4,878,000 -2,475,000 344,000 4,945,000 -291,000 5,151,000 -1,995,000 6,419,000 2,448,000 5,387,000 4,814,000 7,148,000 -4,122,000 7,343,000 3,786,000 2,934,000 -2,064,000 5,144,000 2,647,000 4,116,000                               
      other liabilities
    		-3,305,000 -3,166,000 -6,149,000 -652,000 -10,402,000 -6,619,000 -5,011,000 -12,008,000 -6,144,000 -6,155,000 -4,201,000 -9,690,000 -9,442,000 -1,744,000 877,000 -2,701,000 -9,404,000 14,207,000 -24,620,000 -4,639,000 -18,731,000 34,800,000 -7,912,000 -2,607,000 -10,275,000 -3,612,000 -11,993,000 -1,867,000 -1,030,000 -2,346,000 949,000 -1,519,000 -1,498,000 123,000 2,159,000 738,000 -10,610,000 2,138,000 329,000 -1,471,000 -6,411,000 1,364,000 3,864,000 -219,000 239,000 1,269,000 1,203,000 -500,000 -681,000 1,019,000 1,373,000 -2,230,000 175,000 910,000 1,556,000 -1,097,000 499,000 1,343,000 1,214,000 -169,000 -2,857,000 1,267,000 1,608,000 -1,268,000 189,000 1,560,000 915,000 -4,121,000 5,886,000 2,215,000 -9,205,000 1,297,000 -954,000 -6,378,000 7,936,000               
      net cash from operating activities – continuing operations
    		138,115,000 138,131,000 -116,111,000 134,805,000 95,725,000 109,344,000 -122,624,000 73,003,000 81,116,000 92,606,000 -100,644,000 102,293,000 88,353,000 81,597,000 -89,931,000 75,042,000 67,202,000 70,442,000 -98,926,000 82,243,000 51,752,000 166,324,000 -146,431,000   115,330,000 -60,408,000                                                               
      net cash from operating activities - discontinued operations
    		-830,000 -964,000 -1,352,000  -3,887,000 -2,393,000 -2,602,000  -1,178,000 -3,552,000 -273,000  -5,023,000 810,000 -7,551,000  -6,100,000 -16,855,000 16,738,000      257,000 4,322,000 3,591,000                                                               
      net cash from operating activities
    		137,285,000 137,167,000 -117,463,000 133,010,000 91,838,000 106,951,000 -125,226,000 69,250,000 79,938,000 89,054,000 -100,917,000 98,686,000 83,330,000 82,407,000 -97,482,000 44,236,000 61,102,000 53,587,000 -82,188,000 -11,866,000 169,935,000 192,982,000 -146,431,000 127,621,000 156,181,000 119,652,000 -56,817,000    -113,634,000    -21,763,000    -33,039,000    -53,684,000    -49,822,000    -18,387,000    -32,116,000    -14,461,000    -41,606,000    -22,025,000    -27,313,000    -30,776,000          -7,874,000     
      capex
    		-5,338,000 -4,515,000 -3,318,000 -3,440,000 -6,290,000 -6,962,000 -5,330,000 -9,044,000 -9,154,000 -8,131,000 -6,999,000 -9,058,000 -6,947,000 -6,558,000 -7,145,000 -3,168,000 -10,545,000 -9,484,000 -9,052,000 -6,979,000 1,517,000 -9,613,000 -13,713,000 -6,872,000 -8,529,000 -10,659,000 -5,821,000    -12,426,000    -11,730,000    -10,443,000    -5,388,000    -4,570,000    -4,337,000    -2,920,000    -20,250,000    -4,062,000    -4,484,000    -4,912,000    -1,469,000          -2,399,000     
      free cash flows
    		131,947,000 132,652,000 -120,781,000 129,570,000 85,548,000 99,989,000 -130,556,000 60,206,000 70,784,000 80,923,000 -107,916,000 89,628,000 76,383,000 75,849,000 -104,627,000 41,068,000 50,557,000 44,103,000 -91,240,000 -18,845,000 171,452,000 183,369,000 -160,144,000 120,749,000 147,652,000 108,993,000 -62,638,000    -126,060,000    -33,493,000    -43,482,000    -59,072,000    -54,392,000    -22,724,000    -35,036,000    -34,711,000    -45,668,000    -26,509,000    -32,225,000    -32,245,000          -10,273,000     
      cash flows from investing activities:
    		                                                                                         
      acquisition payments, net of cash acquired
    		   0 0 0 -8,167,000 -5,000,000 0 0 -1,667,000 0 0 -2,500,000 -25,667,000 -10,380,000 -12,343,000 -1,250,000 -5,957,000 0 -2,150,000 0 -75,000 -80,775,000 -19,750,000 -7,200,000 -4,250,000 -87,456,000 -1,460,000 -3,600,000 -21,975,000 -176,612,000 -241,338,000 -2,801,000 -110,945,000 -37,441,000 -529,146,000 -136,175,000 -59,540,000 -12,599,000 -236,839,000 -531,741,000 -37,724,000 -133,323,000 -210,574,000 -66,122,000 -69,375,000 -44,500,000 -76,601,000 -115,649,000 -1,295,000 -238,644,000 -137,493,000 -36,774,000 -28,095,000 -74,957,000 -68,395,000 -1,450,000 -10,083,000 -274,460,000 -5,601,000 -18,350,000 -40,185,000 -47,950,000 -41,148,000 -50,720,000 -11,503,000   -41,099,000 -6,555,000 -17,008,000 -89,441,000 -694,000 -11,958,000   -6,217,000 -19,869,000 -28,931,000 -36,920,000 -23,166,000 -2,977,000 -30,029,000 -8,681,000 -11,934,000 -17,112,000   
      purchases of investments
    		-1,955,000 -13,768,000 -7,761,000 -10,144,000 -14,487,000 -23,019,000 -16,896,000 -5,416,000 -8,716,000 -8,212,000 -9,549,000 -2,408,000 -1,955,000 -11,711,000 -1,272,000 -3,621,000 -3,076,000 -3,217,000 -5,138,000 -25,755,000 -3,755,000 -11,293,000 -21,042,000 -21,194,000    0 0 -1,845,000 -14,039,000 -2,982,000 -9,417,000 -2,919,000 -12,405,000 -10,108,000 -12,189,000 -20,388,000 -18,291,000 -13,598,000 -9,434,000 -7,229,000 -3,719,000 -7,280,000 -9,878,000 -5,822,000 -3,904,000 -1,936,000 -3,920,000 -2,928,000 -12,018,000 -12,021,000 -6,986,000 -8,537,000 -5,576,000 -16,487,000 -18,117,000 -322,000 -7,600,000 -5,056,000 -16,227,000 -2,848,000 -2,347,000            -13,538,000               
      proceeds from maturities or sales of investments
    		3,044,000 11,080,000 7,300,000 7,170,000 14,080,000 17,089,000 14,155,000 6,345,000 3,750,000 5,945,000 6,865,000 1,000,000 1,850,000 6,327,000 7,712,000 1,001,000 4,750,000 3,312,000 7,433,000 2,567,000 12,730,000 8,275,000 9,860,000 24,865,000 18,060,000 3,380,000 4,800,000                                                               
      proceeds from investment in divested business
    		                                                                                         
      purchases of property and equipment
    		-5,338,000 -4,515,000 -3,318,000 -3,440,000 -6,290,000 -6,962,000 -5,330,000 -9,044,000 -9,154,000 -8,131,000 -6,999,000 -9,058,000 -6,947,000 -6,558,000 -7,145,000 -3,168,000 -10,545,000 -9,484,000 -9,052,000 -6,979,000 1,517,000 -9,613,000 -13,713,000 -6,872,000 -8,529,000 -10,659,000 -5,821,000 -10,733,000 -11,861,000 -13,848,000 -12,426,000 -17,333,000 -10,067,000 -10,179,000 -11,730,000 -10,844,000 -9,249,000 -8,728,000 -10,443,000 -7,165,000 -7,239,000 -7,281,000 -5,388,000 -6,656,000 -3,652,000 -3,183,000 -4,570,000 -2,970,000 -3,339,000 -5,008,000 -4,337,000 -4,548,000 -3,126,000 -3,901,000 -2,920,000 -2,710,000 -5,203,000 -3,169,000 -20,250,000 -2,059,000 -2,834,000 -3,158,000 -4,062,000            -1,469,000               
      net cash from investing activities
    		6,604,000 -7,154,000 -7,464,000 -1,938,000 -4,338,000 -12,892,000 -16,238,000 -12,424,000 -14,004,000 -10,398,000 -11,350,000 -11,241,000 -6,088,000 -13,352,000 -26,273,000 -15,584,000 -41,214,000 14,089,000 -10,364,000 840,611,000 -3,441,000 -1,439,000 -20,220,000 156,977,000 -27,219,000 -18,612,000 -8,691,000 -94,989,000 -8,806,000 -16,798,000 -22,176,000 -189,136,000 -247,656,000 -12,361,000 -127,460,000 -49,308,000 -543,364,000 -152,401,000 -76,144,000 -24,614,000 -244,332,000 -535,488,000 -43,566,000 -141,024,000 -217,654,000 -70,712,000 -74,214,000 -44,708,000 -79,810,000 -123,337,000 -15,635,000 -251,103,000 -134,442,000 -45,612,000 -29,391,000 -84,569,000 -79,185,000 6,264,000 -33,083,000 -277,600,000 -17,162,000 -23,356,000 -43,494,000 -47,366,000    -35,764,000    -7,066,000      -8,595,000 -24,799,000 -31,636,000 -39,822,000  -4,398,000 -30,336,000 -11,080,000     
      cash flows from financing activities:
    		                                                                                         
      borrowings on line of credit
    		    0 65,000,000 170,500,000                                      450,000,000 262,500,000 371,500,000 79,500,000 267,000,000 269,500,000 295,500,000 116,000,000 155,500,000 113,000,000 133,000,000 125,000,000 147,500,000 92,500,000 147,500,000 324,500,000 21,500,000 108,500,000 229,500,000 141,000,000 70,500,000 76,000,000 186,000,000 110,000,000 263,100,000 60,700,000 16,000,000          28,000,000      -2,500,000   
      payments on line of credit
    		    0 -145,000,000 -90,500,000                                      -341,000,000 -332,000,000 -150,500,000 -176,000,000 -297,300,000 -299,700,000 -255,500,000 -20,000,000 -107,500,000 -196,500,000 -78,500,000 -146,000,000 -163,500,000 -203,000,000 -117,500,000 -178,000,000 -79,500,000 -179,500,000 -150,500,000 -176,500,000 -137,000,000 -105,000,000 -144,500,000 -141,500,000 -149,600,000 -3,200,000 -16,000,000        -45,200,000           
      payments on term loan
    		-4,688,000 -4,687,000 -4,688,000 -3,125,000 -3,125,000 -3,125,000 -3,125,000 -3,125,000 -3,125,000 -3,125,000 -3,125,000 -3,125,000 -3,125,000                                                                             
      payments on finance lease obligations
    		-502,000 -505,000 -339,000 -843,000 -654,000 -701,000 -690,000 -513,000 -701,000 -701,000 -703,000 -740,000 -914,000 -515,000 -747,000 -1,013,000 -690,000 -434,000 -672,000 -728,000 -247,000 -183,000 -3,000 -51,000 -85,000 -56,000 -42,000                                                               
      proceeds from issuance of common stock
    		700,000 1,176,000 662,000 732,000 897,000 1,149,000 860,000 1,036,000 1,187,000 1,594,000 1,095,000 1,176,000 1,382,000 1,664,000 1,174,000 1,242,000 3,033,000 1,536,000 1,042,000 1,312,000 1,321,000 2,544,000 1,832,000 2,101,000 2,606,000 3,675,000 2,876,000 3,006,000 3,863,000 5,658,000 3,731,000 4,592,000 4,694,000 6,913,000 7,077,000 6,423,000 4,144,000 7,058,000 4,397,000 3,406,000 5,766,000 6,360,000 4,596,000 18,736,000 5,752,000 10,990,000 7,398,000 13,340,000 5,182,000 4,982,000 5,193,000 9,983,000 5,024,000 4,541,000 9,262,000 3,054,000 5,207,000 16,966,000 6,135,000 12,961,000 1,560,000 4,818,000 3,193,000 10,760,000 3,966,000 2,291,000 942,000 1,417,000 1,680,000 3,003,000 5,582,000 2,481,000 19,657,000 2,053,000 3,197,000   17,258,000 8,874,000 16,819,000 8,472,000 6,430,000 3,946,000 7,855,000 15,463,000 7,509,000 9,210,000 10,282,000 935,000 
      repurchases of common stock
    		-20,867,000 -209,000 -1,569,000 -643,000 -162,000 -11,000 -887,000 0 -133,000 -11,000 -775,000 -1,470,000 -21,477,000 -64,398,000 -1,166,000 0 -2,474,000 -251,000 -1,994,000 2,000 -5,452,000 -501,000 -2,542,000 -355,000 -416,000 -65,527,000 -78,982,000 0 -250,000,000   0 0 -2,078,000 -68,114,000 0 0 -3,182,000 -58,646,000 0 -1,450,000 0 -233,601,000 -360,670,000 -1,063,000 -9,707,000 -116,989,000 0                    0 0 -99,997,000 -100,000,000 -32,607,000                  
      net cash from financing activities
    		-28,562,000 -4,259,000 -6,035,000 -4,963,000 -3,071,000 -82,655,000 76,204,000 -4,747,000 -50,604,000 -78,931,000 108,567,000 -86,289,000 -82,662,000 -62,146,000 -256,457,000 825,000 -131,000   586,000 -4,133,000   -209,499,000 -143,150,000                                       -19,914,000              -32,816,000     -31,474,000       
      net increase in cash and cash equivalents
    		   126,109,000    52,079,000        29,477,000 19,757,000 68,527,000 -854,213,000 829,331,000 162,361,000 -175,107,000 199,388,000    1,156,000     31,797,000 7,980,000 -1,416,000 -13,859,000 2,893,000 913,000 -3,599,000 3,919,000 -9,343,000 -4,407,000 15,103,000 2,291,000 -23,894,000   -11,362,000 14,895,000   13,145,000 -44,844,000   3,792,000 -17,153,000    -35,136,000 35,246,000 2,202,000 -2,564,000 5,638,000 2,265,000 -2,743,000 6,997,000   -25,255,000 -63,333,000 52,386,000 -86,099,000 64,974,000 2,037,000   6,414,000    -23,896,000    17,486,000 -1,144,000 -2,074,000 -59,567,000 
      cash and cash equivalents at beginning of period
    		0 0 229,940,000  0 0 73,258,000  0 0 9,824,000  0 0 387,391,000  0 0 1,123,843,000  0 -4,897,000 112,767,000          0 0 55,698,000  0 0 51,572,000  0 0 47,928,000  0 0 31,137,000  0 0 21,280,000  0 0 18,596,000  0 0 26,251,000  0 0 26,503,000  0 0 14,346,000  0 0 102,843,000  0 0 69,595,000    0 0 7,011,000  0 0 27,896,000  0 0 73,195,000 
      cash and cash equivalents at end of period
    		115,327,000 125,754,000 98,978,000  84,429,000 11,404,000 7,998,000  15,330,000 -275,000 6,124,000  -5,420,000 6,909,000 7,179,000  19,757,000 68,527,000 269,630,000  162,361,000            7,980,000 -1,416,000 41,839,000  913,000 -3,599,000 55,491,000  -4,407,000 15,103,000 50,219,000  54,109,000 -2,062,000 19,775,000  3,079,000 -21,262,000 34,425,000  53,978,000 -10,242,000 22,388,000  11,785,000 8,915,000 15,049,000  35,246,000 2,202,000 23,939,000  2,265,000 -2,743,000 21,343,000  -2,097,000 -25,255,000 39,488,000  -86,099,000 64,974,000 71,632,000    -836,000 1,534,000 4,080,000  11,188,000 -4,595,000 24,314,000  -1,144,000 -2,074,000 13,628,000 
      net decrease in cash and cash equivalents
    		 125,754,000 -130,962,000   11,404,000 -65,260,000   -275,000 -3,700,000  -5,420,000 6,909,000 -380,212,000          -14,188,000    -3,595,000 -2,883,000 -19,261,000                           8,915,000 -11,202,000                     1,534,000 -2,931,000   -4,595,000 -3,582,000     
      income from discontinued operations
    		                    33,126,000 682,397,000 2,602,000                                                                   
      adjustments to reconcile net income to net cash provided from operating activities:
    		                                                                                         
      loss on disposal of business
    		                                                                                         
      loss on early extinguishment of debt
    		           0 0 0 57,016,000 0 0 0 14,532,000                                                                       
      income taxes (payable) receivable
    		                                                                                         
      net used in operating activities – discontinued operations
    		                                                                                         
      borrowings on credit agreement
    		       0 49,000,000 205,000,000 216,000,000   226,500,000 248,500,000     0 0 12,500,000 515,000,000 21,500,000 327,300,000 380,000,000 518,500,000 359,000,000 543,000,000 315,500,000 506,000,000 1,590,000,000 435,000,000 284,500,000 536,500,000 279,000,000 759,000,000 352,000,000 550,000,000                                                   
      payments on credit agreement
    		       0 -90,000,000 -278,000,000 -106,000,000   -222,000,000 -99,500,000     0 0 -381,000,000 -146,500,000 -231,300,000 -469,000,000 -420,500,000 -866,000,000 -883,500,000 -428,500,000 -390,000,000 -392,500,000 -1,563,500,000 -381,500,000 -414,000,000 -340,000,000 -362,000,000 -410,500,000 -355,500,000 -382,000,000                                                   
      redemption of senior notes, including call premium
    		           0 0 0 -1,046,880,000 0 0 0 -759,848,000                                                                       
      proceeds from issuance of senior notes and term loan
    		                                                                                         
      payments for credit facility amendment and financing costs
    		                   0 0 -10,000 -500,000                                                                   
      payments of contingent consideration liabilities
    		               0 0 0 -189,000   0 -102,000 -406,000 -346,000 -376,000 -42,000 -407,000 -621,000 0 -65,000 -176,000 -275,000 -255,000 -44,000 -302,000 -234,000 -472,000 -29,000 -394,000 -253,000 -758,000 -34,000 -220,000 -84,000 -988,000 -2,779,000         -2,861,000 0                                 
      cash and cash equivalents at beginning of year
    		                                                                                         
      cash and cash equivalents at end of year
    		                                                                                         
      supplemental disclosure of cash flow information:
    		                                                                                         
      cash paid for:
    		                                                                                         
      interest
    		                                                                                         
      income taxes
    		           26,109,000                                                                              
      non-cash investing and financing activities:
    		                                                                                         
      equipment financed through finance leases
    		                                                                                         
      property and equipment included in accounts payable
    		                                                                                         
      goodwill impairment
    		    0                   0                                                                  
      fixed assets impairments
    		    0                                                                                     
      intangible assets impairments
    		    0                                                                                     
      gain on sale of building
    		               0 0                                                                         
      proceeds from sale of building
    		               0 0                                                                         
      strategic investments
    		               0                                                                          
      net cash from investing activities – continuing operations
    		           -11,241,000 -6,088,000 -13,352,000 -26,273,000 -15,584,000 -41,214,000 14,089,000 -12,714,000 -30,167,000 8,946,000 -16,905,000 -20,220,000   -14,479,000 -5,271,000                                                               
      net cash from investing activities – discontinued operations
    		                                                                                         
      net cash from financing activities – continuing operations
    		           -86,289,000 -82,662,000 -62,146,000 -256,457,000     586,000 -2,885,000                                                                     
      net cash from financing activities – discontinued operations
    		                                                                                         
      proceeds from senior notes and term loan
    		            0 0 650,000,000                                                                           
      payments for financing costs
    		            -227,000 -470,000 -7,924,000         0 0 -814,000 -8,380,000                                                               
      (income) income from discontinued operations
    		               -7,234,000 1,052,000 -4,478,000 -12,290,000                                                                       
      income taxes receivable
    		             -29,470,000 17,216,000 14,106,000 11,774,000 -9,664,000 -18,501,000                                                                       
      payment of contingent consideration liabilities
    		                                                -600,000 -5,300,000 -410,000  0 -4,493,000 -410,000                                   
      net cash from operating activities – discontinued operations
    		                                                                                         
      contribution from noncontrolling interests
    		                   0            0 0 0 894,000         0 0                                             
      cash, cash equivalents at beginning of year
    		                                                                                         
      cash paid (refunded) for:
    		                                                                                         
      loss (income) from discontinued operations
    		              247,000         23,652,000 -4,330,000 43,761,000 284,525,000                                                               
      net cash from investing activities - discontinued operations
    		                0 0 2,350,000      -3,093,000 -4,133,000 -3,420,000                                                               
      borrowings on revolving credit line
    		                                                                                         
      payments on revolving credit line
    		                                                                                         
      net cash from financing activities - discontinued operations
    		                                                                                         
      proceeds from issuance of senior notes
    		                       0 0 0 500,000,000                                                               
      payments for credit facility amendment
    		                                        0                                                 
      contribution from noncontrolling interest
    		                                                                                         
      net cash from from financing activities – continuing operations
    		                                                                                         
      net cash (used in) provided from financing activities – continuing operations
    		                                                                                         
      net cash provided from financing activities – continuing operations
    		                  -761,661,000    366,039,000    66,664,000                                                               
      net cash provided from financing activities - discontinued operations
    		                                                                                         
      net cash provided from financing activities
    		                  -761,661,000    366,039,000    66,664,000    116,549,000 25,298,000 55,706,000 -126,631,000 135,364,000 -78,747,000 348,151,000 -941,000 113,102,000  67,809,000 404,458,000 99,541,000   -65,593,000 112,674,000    47,167,000    65,299,000    36,342,000   -66,135,000 82,536,000           3,280,000 3,524,000      36,235,000         
      proceeds from sales of businesses, net of cash sold
    		                                                                                         
      income taxes payable / receivable
    		                    20,920,000                                                                     
      net cash from operating activities—discontinued operations
    		                                                                                         
      proceeds from sale of business, net of cash sold
    		                    604,000                                                                     
      net cash from investing activities—discontinued operations
    		                    -12,387,000                                                                     
      net cash from financing activities—discontinued operations
    		                                                                                         
      proceeds from sale of business
    		                      4,750,000                                                                   
      less cash and cash equivalents of discontinued operations at end of period
    		                        2,836,000 -189,000 -11,425,000                                                               
      cash and cash equivalents of continuing operations at end of period
    		                      312,155,000                                                                   
      proceeds from sales of businesses
    		                                                                                         
      cash, cash equivalents and restricted cash at beginning of year
    		                                                                                         
      less cash and cash equivalents of discontinued operations at end of year
    		                                                                                         
      cash and cash equivalents and restricted cash at end of year
    		                                                                                         
      value of common stock issued for acquisitions
    		                                                                                         
      net cash from operating activities - continuing operations
    		                                                                                         
      proceeds from sale of controlling interest in assets
    		                           0 0 0 22,764,000                                                           
      net cash from investing activities - continuing operations
    		                                                                                         
      net cash from financing activities - continuing operations
    		                                                                                         
      cash, cash equivalents and restricted cash at beginning of period
    		                        0 0 56,745,000  0 0 80,200,000                                                           
      cash, cash equivalents and restricted cash of continuing operations at end of period
    		                         -6,234,000 46,476,000                                                               
      net cash provided from operating activities
    		                           127,594,000 140,727,000   195,635,000 199,930,000   130,948,000 196,126,000   104,136,000 172,116,000   178,807,000 159,413,000   138,619,000 157,931,000   105,957,000 134,702,000   90,098,000 100,079,000   85,079,000 105,392,000   72,918,000 106,731,000   68,278,000 83,131,000   89,410,000 62,826,000     47,825,000 60,716,000    47,060,000       
      proceeds from maturities of investments
    		                           3,200,000 4,515,000 2,495,000 3,500,000 4,895,000 13,225,000 3,420,000 3,870,000 9,085,000 7,220,000 12,890,000 12,130,000          4,050,000    13,163,000    12,530,000        6,390,000 5,200,000 6,475,000                       
      payments on capital lease obligations
    		                           -343,000 -377,000 -321,000 -315,000 -645,000 -624,000 -421,000 -577,000 -529,000 -674,000 -391,000 -536,000 -1,108,000 -608,000 -296,000 -159,000 -75,000 -42,000 -17,000 -25,000 -23,000 -23,000 -23,000 -30,000 -15,000 -35,000 -43,000 -43,000 -50,000 -59,000 -259,000 -95,000      -70,000 -90,000 -85,000  -64,000 -52,000 -310,000  -47,000       -70,000 -65,000   -113,000 -91,000   -38,000 -51,000 
      excess tax benefit from exercises of stock options and vesting of restricted stock
    		                                      319,000    1,076,000        2,414,000 2,059,000 729,000 1,716,000 1,990,000 145,000 1,743,000 4,841,000 302,000 790,000 115,000 1,728,000 410,000     95,000 85,000 1,653,000 2,298,000 248,000 6,505,000 1,275,000 612,000               
      net cash (used in) provided from financing activities
    		                           -30,321,000 -135,516,000                   -79,016,000                      -37,893,000 -92,430,000 -29,958,000                  
      cash, cash equivalents and restricted cash at end of year
    		                                                                                         
      equipment financed through capital leases
    		                                                                                         
      cash, cash equivalents and restricted cash at end of period
    		                            -3,595,000 -2,883,000 60,939,000                                                           
      other long term assets
    		                                                                                         
      excess tax benefit from exercises of stock options and vesting of restricted and deferred stock
    		                                                                                         
      other assets
    		                                1,775,000 -1,068,000 -2,357,000    1,164,000 -5,341,000 3,121,000 3,154,000 705,000 457,000 1,048,000 291,000 341,000 -533,000 -3,187,000 266,000 -87,000 399,000 214,000 561,000 -21,000 -89,000 1,300,000 222,000 2,499,000 -2,514,000 -185,000 -414,000 -488,000 -2,108,000 -327,000 539,000 227,000 992,000 -4,000 224,000 146,000 -100,000 383,000 -584,000 274,000   -18,000 -853,000 100,000 -69,000  74,000 -64,000 81,000     
      excess tax benefit from vesting of restricted stock and exercises of stock options
    		                                                                                         
      net change in fair value of contingent consideration liabilities
    		                                   180,000 98,000 220,000 274,000 29,000 245,000 -550,000 289,000 89,000 -966,000 114,000 346,000                                           
      equity in earnings of unconsolidated affiliate
    		                                   -806,000 -796,000 -789,000 -794,000 -777,000 -784,000 -745,000 -821,000 -905,000 -725,000                                             
      distribution of earnings from unconsolidated affiliate
    		                                   0    0 0 0 2,062,000                                               
      value of common stock issued for an acquisition
    		                                                                                         
      excess tax benefit from vesting of restricted stock and exercises from stock options
    		                                    70,000                                                     
      prepaid expenses and other assets
    		                                     -3,498,000 1,273,000 -425,000 -1,800,000 -4,679,000 1,999,000 4,674,000 -113,000 -1,575,000 -1,480,000 1,123,000 1,340,000 -3,614,000 1,363,000 -2,033,000 2,529,000 -2,895,000 2,155,000 1,593,000 -5,067,000 291,000 -250,000 250,000 279,000 -175,000 3,528,000 41,000 4,032,000 -6,332,000 1,071,000 -2,232,000 1,039,000 -2,345,000 486,000 -4,551,000 -538,000 -1,855,000 1,852,000   76,000 885,000    -745,000       
      borrowings on credit facility
    		                                       275,000,000 432,000,000 780,000,000 634,500,000                                               
      payments on credit facility
    		                                       -1,099,500,000 -366,000,000 -384,000,000 -306,500,000                                               
      net cash provided from (used in) financing activities
    		                                           -61,677,000        100,302,000              -27,385,000 42,414,000                  15,372,000     
      proceeds from sales or maturities of investments
    		                                        9,180,000 10,763,000 3,265,000 6,235,000 6,450,000 4,415,000 3,635,000    2,015,000    7,200,000    4,850,000 3,975,000 7,500,000 1,000,000 3,100,000     7,949,000 6,500,000 3,714,000 6,570,000 46,345,000 72,960,000 63,015,000 56,254,000               
      excess tax benefit from vesting of restricted and deferred stock and exercises of stock options
    		                                                                                         
      payments for credit facility financing costs
    		                                                                                         
      non-cash financing activities:
    		                                                                                         
      excess tax benefit from exercises of stock options
    		                                            1,343,000 7,881,000 1,935,000                    57,000                       
      payments for amendment of line of credit
    		                                                                                         
      accretion of contingent consideration liabilities
    		                                                610,000 464,000 242,000 232,000 246,000 252,000 265,000 266,000 273,000 279,000 265,000 250,000 268,000 274,000 175,000                           
      excess tax benefit from exercises of stock options and vesting of restricted stock and deferred stock
    		                                                2,562,000                                         
      excess tax benefit related to resolution of income tax matters
    		                                                           0                              
      gain on sale of discontinued operating unit
    		                                                                                         
      proceeds from sale of discontinued operating unit
    		                                                                                         
      payments for syndication of line of credit
    		                                                                                 0        
      payments on long-term debt and capital lease obligations
    		                                                           -61,000 -53,000 -81,000 -67,000            -285,000   -74,000    -66,000        
      cash held by discontinued operating unit
    		                                                                                         
      gain on sale of assets
    		                                                                    0 1,906,000 -38,143,000            0       
      purchase of investments
    		                                                                -5,707,000 -10,014,000 -3,880,000 -5,615,000 -11,922,000 -3,997,000 -4,693,000 -32,761,000 -89,644,000     -3,665,000            
      purchase of property and equipment
    		                                                                -2,803,000 -3,574,000 -4,484,000 -2,729,000 -4,764,000 -3,275,000 -4,912,000 -3,642,000 -1,522,000     -2,313,000 -1,411,000 -2,630,000 -1,531,000 -1,830,000 -1,421,000 -1,407,000 -2,399,000 -1,531,000 -11,403,000 -1,024,000 -1,316,000 
      proceeds from sale of assets
    		                                                                    0 0 66,000,000           0 0       
      payments on syndication of line of credit
    		                                                                                         
      excess tax benefit related to stock option exercises and restricted stock vestings
    		                                                                609,000                         
      cash held by discontinued operating unit at beginning of period
    		                                                                    0 0 50,000                   
      cash held by discontinued operating unit on sale date
    		                                                                    0 0 -72,000                   
      net cash (used in) provided from investing activities
    		                                                                 -59,108,000 -13,392,000                       
      reduction of excess tax benefit related to stock option exercises and restricted stock vestings
    		                                                                                         
      acquisition payments
    		                                                                                         
      net cash provided from investing activities
    		                                                                     -44,657,000 56,410,000                   
      recognition of tax benefits from uncertain tax positions
    		                                                                                         
      cash held by discontinued operating unit at end of year
    		                                                                                         
      recognition of tax benefit from uncertain tax position
    		                                                                        0 0 -1,181,000               
      net cash provided from (used in) investing activities
    		                                                                         -5,368,000 29,289,000               
      net income, as restated
    		                                                                                         
      add: stock based compensation expense related to stock options and restricted stock included in restated net income, net of related tax effects
    		                                                                                         
      deduct: total stock-based employee compensation expense related to stock options and restricted stock determined under fair value accounting rules net of related tax effect
    		                                                                                         
      pro forma net income, as restated
    		                                                                                         
      net income per share
    		                                                                                         
      as restated:
    		                                                                                         
      basic
    		                                                                                         
      diluted
    		                                                                                         
      pro forma, as restated:
    		                                                                                         
      •
    		                                                                                         
      purchase of short-term investments
    		                                                                               -4,575,000 -3,871,000         
      maturities of short-term investments
    		                                                                               4,500,000 2,500,000         
      payments to refinance line of credit
    		                                                                              0 0 -172,000         
      equity-based compensation expense
    		                                                                             5,476,000            
      maturities of investments
    		                                                                             3,600,000            
      (payments) borrowings on line of credit
    		                                                                                         
      non-cash financing activity:
    		                                                                                         
      common stock issued for convertible notes
    		                                                                                         
      purchase of treasury stock
    		                                                                                  -34,127,000   0 -25,233,000 -24,787,000 -49,982,000 
      adjustments to reconcile net income to net cash provided from (used in) operating activities:
    		                                                                                         
      net cash provided from (used in) operating activities
    		                                                                                656,000         
      cash flows provided from (used in) investing activities:
    		                                                                                         
      cash flows provided from (used in) financing activities:
    		                                                                                         
      income taxes payable/receivable
    		                                                                                  6,151,000       
      payments on long-term debt, capital lease obligations and note payable
    		                                                                                         
      adjustments to reconcile net income to net cash (used in) provided from operating activities:
    		                                                                                         
      physician group acquisition payments
    		                                                                                        -2,660,000 
      cash flows used in investing activities:
    		                                                                                         
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.